Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1367 Events

🤖 AI Analyzed

Recent

📄 Page 112 of 114

Arbutus Biopharma Corp

8-K March 23, 2026

Key Highlights

$2.25 billion settlement with Moderna, including $467.5 million upfront cash for...
Potential for an additional $642.5 million from Moderna contingent on '435 paten...
Imdusiran shows positive Phase 2a results with 10 out of 24 patients achieving a...

Read Analysis

🤖 AI Generated

TWO HARBORS INVESTMENT CORP.

8-K March 23, 2026

Key Highlights

A bidding war has begun for Two Harbors Investment Corp., potentially driving th...
Shareholders could receive a higher cash payout, with the latest offer at $10.75...
Multiple companies see significant value in Two Harbors' residential mortgage-ba...

Read Analysis

🤖 AI Generated

FuboTV Inc.

8-K March 23, 2026

Key Highlights

FuboTV (FUBO) executed a 1-for-12 reverse stock split to reduce share count and ...
The split aims to meet NYSE minimum price requirements ($1.00 per share) and avo...
It seeks to improve market perception, attract larger institutional investors wh...

Read Analysis

🤖 AI Generated

FG Nexus Inc.

8-K March 23, 2026

Key Highlights

FG Nexus Inc. completed the sale of its Reinsurance Division, marking a signific...
Received a substantial immediate cash injection of $4.3 million ($1.0M final pay...
Retains 40% ownership in Devondale Holdings, LLC, allowing continued benefit fro...

Read Analysis

🤖 AI Generated

Aurinia Pharmaceuticals Inc.

8-K March 23, 2026

Key Highlights

Aurinia Pharmaceuticals undergoes a major leadership shake-up with new CEO, COO,...
New CEO Kevin Tang, a seasoned biotech investor, will take no salary, bonuses, o...
The new leadership team brings extensive experience in strategy, finance, and op...

Read Analysis

🤖 AI Generated

Ondas Inc.

8-K March 23, 2026

Key Highlights

Ondas Inc. is acquiring World View Enterprises Inc., a leader in high-altitude b...
This acquisition expands Ondas's offerings from industrial drones to stratospher...
The deal opens new markets for Ondas in government, defense, and scientific rese...

Read Analysis

🤖 AI Generated

AMERICAN REBEL HOLDINGS INC

8-K March 23, 2026

Key Highlights

Company implements a 1-for-100 reverse stock split to meet Nasdaq's minimum $1.0...
The split aims to make the stock more attractive to a broader range of investors...
Fractional shares resulting from the split will be rounded up to the nearest who...

Read Analysis

🤖 AI Generated

Crypto Co

8-K March 23, 2026

Key Highlights

Net reduction of 281,884,935 Crypto Co shares, potentially boosting profit per s...
Cancellation of loans to Starchive's owners improves Crypto Co's financial healt...
Maximum financial responsibility for the unwound deal is capped at $500,000, sig...

Read Analysis

🤖 AI Generated

Fathom Holdings Inc.

8-K March 23, 2026

Key Highlights

Fathom Holdings secured a $2 million Bridge Note loan.
The loan provides Fathom with needed cash, offering a temporary lifeline.
Fathom is a tech-focused real estate company with an agent-friendly commission m...

Read Analysis

🤖 AI Generated

M2i Global, Inc.

8-K March 23, 2026

Key Highlights

M2i Global settled a major lawsuit, avoiding an $18 million cash payment or issu...
The company resolved the legal dispute by issuing 12.5 million shares, significa...
This settlement removes a major legal cloud and brings much-needed certainty, al...

Read Analysis

🤖 AI Generated

Aardvark Therapeutics, Inc.

8-K March 23, 2026

Key Highlights

Strong financial position with $110.0 million in cash and investments as of Dece...
Cash runway extends into mid-2027, providing crucial financial breathing room to...
Heart-related observations (QRS prolongation) were reversible and occurred at a ...

Read Analysis

🤖 AI Generated

ABBOTT LABORATORIES

8-K March 23, 2026

Key Highlights

Abbott acquired Exact Sciences, a leader in cancer screening and diagnostics, kn...
Significantly expands Abbott's high-growth diagnostics business, especially in c...
Strengthens Abbott's market position in molecular diagnostics and enhances its c...

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage